ATM Kinase Inhibition Preferentially Sensitizes p53-Mutant Glioma to Ionizing Radiation-Reference-Cited by-同舟云学术

ATM Kinase Inhibition Preferentially Sensitizes p53-Mutant Glioma to Ionizing Radiation

Published:2013-04-25 Issue:12 Volume:19 Page:3189-3200
ISSN:1078-0432
Container-title:Clinical Cancer Research
language:en
Short-container-title:Clin Cancer Res

Author:

Biddlestone-Thorpe Laura,Sajjad Muhammad,Rosenberg Elizabeth,Beckta Jason M.,Valerie Nicholas C.K.,Tokarz Mary,Adams Bret R.,Wagner Alison F.,Khalil Ashraf,Gilfor Donna,Golding Sarah E.,Deb Sumitra,Temesi David G.,Lau Alan,O'Connor Mark J.,Choe Kevin S.,Parada Luis F.,Lim Sang Kyun,Mukhopadhyay Nitai D.,Valerie Kristoffer

Publisher

American Association for Cancer Research (AACR)

Subject

Cancer Research,Oncology

Cited by 172 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Targeting the ATM pathway in cancer: Opportunities, challenges and personalized therapeutic strategies;Cancer Treatment Reviews;2024-09

2. Small Molecular Inhibitors That Target ATM for Drug Discovery: Current Research and Potential Prospective;Journal of Medicinal Chemistry;2024-08-16

3. ATM inhibition exploits checkpoint defects and ATM-dependent double strand break repair in TP53-mutant glioblastoma;Nature Communications;2024-06-21

4. Preclinical Systemic Pharmacokinetics, Dose Proportionality, and Central Nervous System Distribution of the ATM Inhibitor WSD0628, a Novel Radiosensitizer for the Treatment of Brain Tumors;Journal of Pharmacology and Experimental Therapeutics;2024-06-10

5. A Novel Dual ATM/DNA-PK Inhibitor, XRD-0394, Potently Radiosensitizes and Potentiates PARP and Topoisomerase I Inhibitors;Molecular Cancer Therapeutics;2024-04-08